Nayapime-TZ 281.25mg Injection
Marketer
Accilex Nutricorp
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Nayapime-TZ 281.25mg Injection
Combithrom 281.25mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under a physician's guidance. Complete the prescribed regimen, regardless of symptom improvement; missed doses should be avoided. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) are common and usually resolve spontaneously. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, itching, swelling, breathing difficulty). Disclose all current medications to your doctor before use. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, refrain from driving if drowsiness or dizziness occurs.
Uses of Nayapime-TZ 281.25mg Injection
Infections caused by bacteria
Major Benefits of Nayapime-TZ 281.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nayapime-TZ 281.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Nayapime-TZ 281.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nayapime-TZ 281.25mg Injection works:
Nayapime-TZ Injection (281.25mg) combines cefepime, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thus overcoming bacterial resistance and improving cefepime's effectiveness.
SAFETY ADVICE
AlcoholCAUTION
Use of Nayapime-TZ 281.25mg Injection warrants caution if alcohol is also consumed. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Nayapime-TZ 281.25mg is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Nayapime-TZ (281.25 mg) poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, and thus no demonstrable harm to the infant.
DrivingUNSAFE
Following administration of Nayapime-TZ 281.25mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Caution is advised when administering Nayapime-TZ 281.25mg Injection to individuals with impaired renal function. Dosage modification of Nayapime-TZ 281.25mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Nayapime-TZ 281.25mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Nayapime-TZ 281.25mg Injection :
Should you forget a Nayapime-TZ 281.25mg Injection, seek your physician's advice.
Facts to Know About Nayapime-TZ 281.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Drugs to combat infection |
3,018 People bought this recently